Clinical Trials Logo

Clinical Trial Summary

Silent Night is a solution for primary snorers to guide them to the proper anti-snoring solution. It consists of a mobile application, which had an intake questionnaire, guides users to one of three anti-snoring solutions; a nasal dilator called, Mute (Rhinomed, Australia), a mandibular advancement device called myTAP V (Airway Management, Austin, TX) and a Sleep Positional Trainer SPT (SPT) (NightBalance, Netherlands). The Silent Night app also records snoring through the night and provides feedback to the user via a "snore score."


Clinical Trial Description

Silent Night is a solution for primary snorers to guide them to the proper anti-snoring solution. It consists of a mobile application, which had an intake questionnaire, guides users to one of three anti-snoring solutions; a nasal dilator called, Mute (Rhinomed, Australia), a mandibular advancement device called myTAP V (Airway Management, Austin, TX) and a Sleep Positional Trainer SPT (SPT) (NightBalance, Netherlands). The Silent Night app also records snoring through the night and provides feedback to the user via a "snore score."

The objective of this trial is twofold. First, each of the interventions to be studied are known to be effective for snoring cessation. However, each is not fully effective in the total population. Their effectiveness is predicated on how an individual snores and where the snore anatomically originates. I.e. if someone position ally snores because their tongue moves back in their mouth, it is unlikely a nasal dilator will work for that individual. In order to improve the SilentNight recommendation algorithm more information needs to be gathered. By asking a battery of questions of a snorer, and having them trial all three snoring solutions it may be possible to understand the comparative effectiveness of each solution, the user acceptance of each solution and which questions should be used to discern what solution will work best for a given individual.

The second objective is to collect "in the wild" audio of snoring. The goal of this data collection, is to identify unique characteristics in the sound recording. These paired with the answers to the intake questions, and the relative effectiveness of the three anti-snoring solutions could phenotype the snore and snorer. This audio data could also be used to develop or refine a "snore score", a semi-objective assessment of snoring audio.

To accomplish these goals, a feasibility, crossover, in home study will be conducted. Up to 30 couples will be recruited to try each of the anti-snoring solutions over an approximately 5 week period. The participant couples will consist of a snorer and a bed partner. The snorer will use the three solutions (1 week for Mute, 2 weeks for myTAP and SPT) and give feedback on the devices, and sleep quality. The bed partner will also provide feedback on their sleep quality, the loudness of snoring and their perception of the device (as a non-user). They will also record bedroom sound during each night of the trial, including a baseline period where no snoring will take place. Each morning the bed partner will rate the snoring severity.

The primary endpoint will be the daily rating of snoring severity as rated by the bed partner. The daily responses will be averaged on a weekly basis. Due to titration and acclimation during the first 9 nights of use nights 10-14 of myTAP V and SPT use will be compared to the week of Mute use. If formal statistical comparisons are performed, continuous data will be compared between the three therapies using repeated-measures ANOVA or the non-parametric Friedman Test, depending on the distributions of the endpoints. If an overall significant effect is observed, post-hoc pairwise tests will be done with a suitable adjustment for multiple comparisons. Categorical data will be compared between therapies using the Cochran's Q test. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03333876
Study type Interventional
Source Philips Respironics
Contact
Status Completed
Phase N/A
Start date October 9, 2017
Completion date December 3, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Active, not recruiting NCT02470182 - Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors
Completed NCT03964324 - NO Measurements in Screening for Asthma and OSA, in Patients With Severe Snoring N/A
Completed NCT06186687 - Rehabilitative Approaches: Myofunctional Therapy and Retropalatal Narrowing and Snoring N/A
Completed NCT03640793 - Prospective Evaluation of a Palato-Pharyngeal Implant System (PPIS) Obstructive Sleep Apnea Syndrome (OSAS) N/A
Not yet recruiting NCT04143022 - Evaluation of the Effects of Acupuncture Press Needle in Mild to Moderate Obstructive Sleep Apnea Patients N/A
Completed NCT02834767 - Genioglossus Muscle Training for Snoring and Obstructive Sleep Apnea N/A
Terminated NCT01772017 - A Trial to Evaluate a Device for the Treatment of OSA and Snoring N/A
Withdrawn NCT01680380 - Tracking Breathing During Sleep With Non-contact Sensors N/A
Unknown status NCT00806637 - Vessel Sealing System Uvulopalatoplasty Versus Uvulopalatal Flap N/A
Completed NCT00560859 - Childhood Adenotonsillectomy Study for Children With OSAS N/A
Terminated NCT03701165 - The Effect of the DryMouth Shield on Snoring N/A
Active, not recruiting NCT05643352 - Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring N/A
Recruiting NCT05756647 - Mandibular Advancement vs Home Treatment for Primary Snoring Phase 2
Completed NCT04086407 - Apnea Hypopnea Index Severity Versus Head Position During Sleep N/A
Not yet recruiting NCT05116657 - Obstructive Sleep Apnoea Post Covid 19: Role of the Upper Airway Microbiome
Completed NCT01491828 - Study to Determine Results of Vibratory Stimulus on Subject's Neck Phase 1
Completed NCT01322334 - Singing Exercises to Improve Symptoms of Snoring and Sleep Apnea N/A
Terminated NCT03316963 - Neostigmine For Snoring During DISE Early Phase 1
Completed NCT04063917 - Safety, and Tolerability of the ZENS Device (PLUTO) N/A